Financials
Financial year 2025
DR. DAPHNE SERRUYS - ONCOLOGIE from Gent, company number BE0763780770, closed financial year 2025 with a result of € 132,832 after tax. For that financial year DR. DAPHNE SERRUYS - ONCOLOGIE recorded a gross margin of € 218,424 and equity of € 731,969. Compared with financial year 2024, the result moved from € 188,444 to € 132,832. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.
€ 731,969
▲ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 132,832
▼ 30% vs 2024
Profit after tax over the fiscal year.
€ 216,498
▼ 28% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 726,969.
People and assets in 2025
€ 5,409
▼ 48% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 48,378
▼ 1% vs 2024
€ 11,125 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 2,381
▼ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 247,059 | € 334,449 | € 330,563 | € 218,424 | ▼ 34% |
| Profit after taxes | € 150,800 | € 195,634 | € 188,444 | € 132,832 | ▼ 30% |
| Equity | € 215,059 | € 410,693 | € 599,137 | € 731,969 | ▲ 22% |
| Total debts | € 181,005 | € 189,945 | € 66,502 | € 55,402 | ▼ 17% |
| Cash | € 169,640 | € 214,734 | € 300,764 | € 216,498 | ▼ 28% |
| Retained profit | € 210,059 | € 405,693 | € 594,137 | € 726,969 | ▲ 22% |
| Bank debt | € 86,794 | € 67,895 | € 48,659 | € 48,378 | ▼ 1% |
| Balance sheet total | € 396,064 | € 600,638 | € 665,640 | € 787,372 | ▲ 18% |
Key figures of DR. DAPHNE SERRUYS - ONCOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR. DAPHNE SERRUYS - ONCOLOGIE?
What happened at DR. DAPHNE SERRUYS - ONCOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 132,832 (▼ 30% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Gent. KBO
In short
From € 150,800 profit in 2022 to € 132,832 profit in 2025.
Paid € 292,052 in corporate taxes since 2022.
Best year ever: 2023, with € 195,634 profit.
Management
Behind DR. DAPHNE SERRUYS - ONCOLOGIE is Daphne SERRUYS.
Directors
According to the 2025 annual accounts
Daphne SERRUYS
Director
Establishments
Establishment units
Physical locations of this company
Meulesteedsesteenweg 191
9000 Gent
Groene Briel,1 Klin.Heil.Familie 1
9000 Gent
Active since 18 February 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- SERRUYS Daphne Floortje Hanne(oprichter) 100%
Details
- Company number
- 0763.780.770
- VAT number
- BE 0763.780.770
- Registered office
- Meulesteedsesteenweg 191, 9000 Gent
- Names & denominations
- DR. DAPHNE SERRUYS - ONCOLOGIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 February 2021
- Peppol
- Active · Active since 28 Jul 2026
- Activities · NACE
Activiteiten van medisch specialisten